This company listing is no longer active
DSM Stock Overview
Provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. More details
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
DSM-Firmenich AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €114.05 |
52 Week High | €160.10 |
52 Week Low | €105.80 |
Beta | 0.72 |
1 Month Change | -3.96% |
3 Month Change | -4.32% |
1 Year Change | -26.49% |
3 Year Change | -3.96% |
5 Year Change | 28.70% |
Change since IPO | 1,649.00% |
Recent News & Updates
Recent updates
Analyst Forecasts For Koninklijke DSM N.V. (AMS:DSM) Are Surging Higher
May 04Koninklijke DSM (AMS:DSM) Is Reinvesting At Lower Rates Of Return
Mar 27Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 09Here's Why We Think Koninklijke DSM (AMS:DSM) Is Well Worth Watching
Dec 06Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Nov 18Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)
Oct 31Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching
Sep 19Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?
Aug 23Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?
Aug 08Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)
Jul 23Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 30Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70
Apr 16Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's
Apr 02Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70
Mar 19Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly
Feb 19Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?
Nov 23We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt
Oct 01Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?
Aug 24Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet
Jun 29Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price
May 24Is Koninklijke DSM (AMS:DSM) A Risky Investment?
Mar 29Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?
Mar 15Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 01Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment
Feb 16Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares
Feb 04Shareholder Returns
DSM | NL Chemicals | NL Market | |
---|---|---|---|
7D | 0.3% | -3.3% | -0.4% |
1Y | -26.5% | -4.9% | 5.0% |
Return vs Industry: DSM underperformed the Dutch Chemicals industry which returned -20.7% over the past year.
Return vs Market: DSM underperformed the Dutch Market which returned 9.1% over the past year.
Price Volatility
DSM volatility | |
---|---|
DSM Average Weekly Movement | 3.2% |
Chemicals Industry Average Movement | 3.7% |
Market Average Movement | 4.1% |
10% most volatile stocks in NL Market | 7.4% |
10% least volatile stocks in NL Market | 2.2% |
Stable Share Price: DSM has not had significant price volatility in the past 3 months.
Volatility Over Time: DSM's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1902 | 19,973 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG, a science-based company, engages in health and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants.
DSM-Firmenich AG Fundamentals Summary
DSM fundamental statistics | |
---|---|
Market cap | €763.73m |
Earnings (TTM) | €454.00m |
Revenue (TTM) | €8.39b |
1.7x
P/E Ratio0.1x
P/S RatioIs DSM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DSM income statement (TTM) | |
---|---|
Revenue | €8.39b |
Cost of Revenue | €5.70b |
Gross Profit | €2.69b |
Other Expenses | €2.24b |
Earnings | €454.00m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 02, 2023
Earnings per share (EPS) | 67.80 |
Gross Margin | 32.06% |
Net Profit Margin | 5.41% |
Debt/Equity Ratio | 26.6% |
How did DSM perform over the long term?
See historical performance and comparison